Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial.
Bashir T, Achison M, Adamson S, Akpan A, Aspray T, Avenell A, Band MM, Burton LA, Cvoro V, Donnan PT, Duncan GW, George J, Gordon AL, Gregson CL, Hapca A, Hume C, Jackson TA, Kerr S, Kilgour A, Masud T, McKenzie A, McKenzie E, Patel H, Pilvinyte K, Roberts HC, Rossios C, Sayer AA, Smith KT, Soiza RL, Steves CJ, Struthers AD, Tiwari D, Whitney J, Witham MD, Kemp PR. Bashir T, et al. Among authors: duncan gw. PLoS One. 2023 Nov 14;18(11):e0294330. doi: 10.1371/journal.pone.0294330. eCollection 2023. PLoS One. 2023. PMID: 37963137 Free PMC article. Clinical Trial.
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial.
Rossios C, Bashir T, Achison M, Adamson S, Akpan A, Aspray T, Avenell A, Band MM, Burton LA, Cvoro V, Donnan PT, Duncan GW, George J, Gordon AL, Gregson CL, Hapca A, Hume C, Jackson TA, Kerr S, Kilgour A, Masud T, McKenzie A, McKenzie E, Patel H, Pilvinyte K, Roberts HC, Sayer AA, Smith KT, Soiza RL, Steves CJ, Struthers AD, Tiwari D, Whitney J, Witham MD, Kemp PR. Rossios C, et al. Among authors: duncan gw. PLoS One. 2023 Oct 20;18(10):e0292402. doi: 10.1371/journal.pone.0292402. eCollection 2023. PLoS One. 2023. PMID: 37862321 Free PMC article. Clinical Trial.
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial.
LACE study group; Achison M, Adamson S, Akpan A, Aspray T, Avenell A, Band MM, Bashir T, Burton LA, Cvoro V, Donnan PT, Duncan GW, George J, Gordon AL, Gregson CL, Hapca A, Henderson E, Hume C, Jackson TA, Kemp P, Kerr S, Kilgour A, Lyell V, Masud T, McKenzie A, McKenzie E, Patel H, Pilvinyte K, Roberts HC, Rossios C, Sayer AA, Smith KT, Soiza RL, Steves CJ, Struthers AD, Sumukadas D, Tiwari D, Whitney J, Witham MD. LACE study group, et al. Among authors: duncan gw. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):858-871. doi: 10.1002/jcsm.12934. Epub 2022 Feb 16. J Cachexia Sarcopenia Muscle. 2022. PMID: 35174663 Free PMC article. Clinical Trial.
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study.
Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T. Vijiaratnam N, et al. Among authors: duncan gw. BMJ Open. 2021 May 28;11(5):e047993. doi: 10.1136/bmjopen-2020-047993. BMJ Open. 2021. PMID: 34049922 Free PMC article.
Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease.
Wilson J, Yarnall AJ, Craig CE, Galna B, Lord S, Morris R, Lawson RA, Alcock L, Duncan GW, Khoo TK, O'Brien JT, Burn DJ, Taylor JP, Ray NJ, Rochester L. Wilson J, et al. Among authors: duncan gw. Mov Disord. 2021 Mar;36(3):611-621. doi: 10.1002/mds.28453. Epub 2020 Dec 31. Mov Disord. 2021. PMID: 33382126 Free PMC article.
Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease.
Ramsay N, Macleod AD, Alves G, Camacho M, Forsgren L, Lawson RA, Maple-Grødem J, Tysnes OB, Williams-Gray CH, Yarnall AJ, Counsell CE; Parkinson's Incidence Cohorts Collaboration; PINE Study; CamPaIGN study; PICNICS study; NYPUM Study; ParkWest Study: ParkWest Principal investigators; Study personnel; ICICLE-PD Study. Ramsay N, et al. Parkinsonism Relat Disord. 2020 Jul;76:49-53. doi: 10.1016/j.parkreldis.2020.05.034. Epub 2020 May 30. Parkinsonism Relat Disord. 2020. PMID: 32645619
Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD.
Stuart S, Lawson RA, Yarnall AJ, Nell J, Alcock L, Duncan GW, Khoo TK, Barker RA, Rochester L, Burn DJ; ICICLE-PD study group. Stuart S, et al. Among authors: duncan gw. Mov Disord. 2019 Nov;34(11):1690-1698. doi: 10.1002/mds.27813. Epub 2019 Aug 23. Mov Disord. 2019. PMID: 31442355
116 results